Furthermore, Wang et al. confirmed that RKIP decreased the metastasis of NSCLC via EMT by observing increased levels of E-cadherin, an epithelial biomarker, and decreased levels of vimentin, a biomarker of mesenchymal cells [209]. The gene discussed is VIM; the disease is non-small cell lung carcinoma.